TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17.

Richard Cathomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.